Sweden: Mathieu made CEO and president at Immunovia

Nasdaq Stockholm-listed diagnostic company Immunovia has named Philipp Mathieu as CEO and president following a search, instigated in December 2021, to replace exiting CEO Patrik Dahlen. Mathieu has been acting CEO and president since January 2022. “After carefully evaluating external candidates, the board has decided that [Mathieu] with his extensive financial background and experience is…

You must be a HMI Subscriber to view this content.

Subscribe Now »